A compound derived from Indian tobacco has the potential to ameliorate some symptoms of Alzheimer’s disease, a recent study by a group of Kerala scientists has found.
A study by researchers at the Jubilee Centre for Medical Research, Thrissur, under Kannur University and the Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, has revealed a promising compound named lobeline, extracted from a plant Lobelia inflata, commonly known as ‘Indian tobacco’.
Developing drugs for Alzheimer’s disease is challenging due to its complex pathology. Impaired glutamatergic signalling is considered to be an important cause of neurological and psychiatric disorders.
